Circassia Pharmaceuticals Plc Total Voting Rights Update (6962G)
May 31 2017 - 4:59AM
UK Regulatory
TIDMCIR
RNS Number : 6962G
Circassia Pharmaceuticals Plc
31 May 2017
For immediate release
Circassia Pharmaceuticals plc
Total Voting Rights Update
31(st) May 2017
In accordance with the requirements of the FCA's Disclosure and
Transparency Rule 5.6.1, Circassia Pharmaceuticals plc ("Circassia"
or "the Company") (LSE: CIR) confirms that the Company's issued
share capital consists of 332,244,588 ordinary shares of 0.08p each
in issue, each with equal voting rights. No shares are held in
treasury.
The above figure may be used by shareholders as the denominator
for the calculations by which they will determine whether they are
required to notify their interest, or a change to their interest,
in the Company under the FCA's Disclosure and Transparency
Rules.
-Ends-
For further information, please contact:
Circassia Pharmaceuticals plc +44 (0) 1865
Julien Cotta, Company Secretary 405560
This information is provided by RNS
The company news service from the London Stock Exchange
END
TVRGCGDUCUXBGRB
(END) Dow Jones Newswires
May 31, 2017 05:59 ET (09:59 GMT)
Circassia (LSE:CIR)
Historical Stock Chart
From Apr 2024 to May 2024
Circassia (LSE:CIR)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Circassia Group Plc (London Stock Exchange): 0 recent articles
More Circassia Pharmaceuticals News Articles